MetaCap

Keros Therapeutics Statistics

NASDAQ: KROSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.08-0.31 (-2.72%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Keros Therapeutics by the numbers

Keros Therapeutics has a market capitalization of $217.4 million based on 19.62M shares outstanding. With trailing EPS of $-2.32, Keros Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.4% above its 50-day average and 3.3% below its 200-day average.

Average daily trading volume is 196.50K shares, or about $2.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

KROS valuation vs. peer median

KROS compared with the median of 8 peer companies
MetricKROSPeer medianDifference
Market cap$217.44M$215.61M+1%
Avg. volume196.50K954.92K-79%

Peer median across 8 companies: RCKT, PYXS, IMRX, ARCT, ENTA, CYPH, VNDA, FTH.

Valuation

Market cap
$217.44M
Price / sales (latest FY)
0.89
EPS (TTM)
$-2.32

Price and trading

Previous close
11.39
Open
11.13
Day range
11.04 – 11.59
52-week range
8.98 – 22.55
52-week change
-36.29%
Beta
—
Volume
208.69K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
217.44M
Forward Pe
-1.93
Eps
-2.32
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
22.55
Week52 Low
8.98
Avg Volume
196.50K
Shares Outstanding
19.62M
Ma50
11.03
Ma200
11.45
Earnings Date
Nov 5, 2026
Pct From52w High
-50.86%
Pct From52w Low
23.39%

Related